Cancer BiologybioRxivPreprint
Site-Specific Immune and Stromal Architecture Drive Resistance to Trastuzumab Deruxtecan in HER2+ Metastatic Breast Cancer
Glori Das, Matthew Vasquez, Jeffrey Zhang…·Stephen T.C. Wong
This study identifies immune and stromal factors driving resistance to Trastuzumab Deruxtecan in HER2+ metastatic breast cancer using spatial proteomics.
3 citations